Abridge
Founded Year
2018Stage
Series E | AliveTotal Raised
$757.5MValuation
$0000Last Raised
$300M | 18 days agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+61 points in the past 30 days
About Abridge
Abridge works with generative AI for clinical conversations within the healthcare sector. The platform converts patient-clinician conversations into structured clinical notes, which supports documentation for healthcare providers. Abridge serves the healthcare technology industry and focuses on clinician experiences and healthcare documentation. Abridge was formerly known as Intelligible AI. It was founded in 2018 and is based in Pittsburgh, Pennsylvania.
Loading...
Abridge's Product Videos
ESPs containing Abridge
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The clinical documentation solutions market includes companies leveraging technologies to streamline and improve the process of capturing, organizing, and using patient information. It includes solutions such as ambient documentation platforms that can document patient-clinician interactions, extract relevant medical information, and integrate with electronic health record (EHR) systems. Uses case…
Abridge named as Leader among 15 other companies, including Microsoft, Oracle, and Amazon.
Abridge's Products & Differentiators
Abridge for Clinicians
Abridge creates artifacts for 3 masters – billing, clinicians, patients. The technology acts as an intelligent copilot, producing organized drafts and providing interactive tools to accelerate editing, and seamlessly integrates with healthcare software to streamline documentation. Health systems trust Abridge: Science. Founded on CMU roots, Abridge’s research culminated in the first-published and first-to-market AI system for generating SOAP note drafts. Abridge’s cutting-edge ML safeguards providers & patients by focusing on causality, fairness, and transparency. Clinician-led. Abridge is building a solution for providers by providers. Through his experience as a cardiologist, Abridge’s co-founder and CEO saw opportunities to improve the gap between medical conversations and what happens next. Patient value. Abridge is the
Loading...
Research containing Abridge
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Abridge in 13 CB Insights research briefs, most recently on May 1, 2025.
May 1, 2025 report
State of AI Q1’25 Report
Apr 17, 2025 report
State of Digital Health Q1’25 Report
Dec 3, 2024 report
Digital Health 50: The most promising digital health startups of 2024
Jul 2, 2024 team_blog
How to buy AI: Assessing AI startups’ potential
May 24, 2024
The generative AI market mapExpert Collections containing Abridge
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Abridge is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,276 items
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,122 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Digital Health 50
200 items
2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.
Generative AI
2,314 items
Companies working on generative AI applications and infrastructure.
Artificial Intelligence
10,047 items
Latest Abridge News
Jul 5, 2025
半年融资66亿+，2家IPO！这个赛道批量制造独角兽 云知声的上市不过是近来全球医疗环境AI（Ambient AI）赛道火热前景的又一缩影。就在数日前，该赛道新秀Abridge刚刚完成高达3亿美元的E轮融资，其估值已达到53亿美元之多。 值得一提的是，Abridge此轮融资领投方为全球顶级风投a16z，这家管理资金超过百亿美元的知名VC眼光毒辣，此前曾押中Facebook、Twitter、Groupon、Skype、Airbnb、Github等互联网巨头。顶级VC的大手笔投资，无疑代表了对医疗环境AI赛道的看好。 在过去的一年中，这一领域利好不断，呈现出一派欣欣向荣的景象。 4个月连续两轮过亿美元大额融资，即使在前几年市场最热的时期也极为罕见。 除了赛道的火热，Abridge自身的营收规模也是其吸引顶级资本下场的原因。非公开数据显示，Abridge在2025年上半年实现的合同年度经常性收入约为1.17亿美元，颇为亮眼。 作为Abridge主要的竞争对手，Commure也在6月完成了高达2亿美元的最新一轮融资。这家企业几乎在各条业务线上都与Abridge直接竞争。尤其在去年7月，Commure宣布以1.39亿美元收购医疗环境AI企业Augmedix，极大提升了在该领域的话语权。 事实上，过去一段时间，该领域的主要企业迎来了密集融资，连续完成两轮融资的企业大有人在。密度之高，额度之大，令人仿佛重回数字医疗的“资本盛世”。 医疗环境AI近期融资事件不完全统计（动脉网制图） 在受到科技巨头的挑战后，Nuance将业务重心转向医疗领域。医疗业务很快成为Nuance占比最大、最具优势的业务。从2013年开始，语音导航系统、语音转写、实时听写、CDI（临床归档改进）等医疗业务的营收在其总营收占比超过四成，并在2016年占比超过五成。 2016年，Nuance的医疗解决方案已经覆盖全美72%的医疗机构，客户遍及全球30多个国家和地区，有50多万临床医生以及1万多家医疗机构在使用Nuance的产品和服务。此时，Abridge还未成立，可见Nuance的资历之深。 2021年4月，微软宣布以197亿美元巨资收购Nuance。这笔交易是微软成立迄今第三大收购案，由此可见微软对Nuance，以及背后医疗环境AI潜力的看好。 不光在国外，国内这一赛道同样在最近连续迎来里程碑。去年年底，被公认为Nuance国内对标的科大讯飞将其医疗业务子公司——讯飞医疗独立上市，发行价格为82.8港元，截至7月2日，股价较发行价已上涨25%，达到103.5港元。 自2016年成立以来，讯飞医疗一直是科大讯飞包括语音AI在内全栈AI能力落地的最佳示范场景之一，营收规模也是国内医疗AI的翘楚。根据招股书，2021-2023年，讯飞医疗分别取得3.72亿元、4.72亿元及5.56亿元。2024年，其营收达到7.34亿元同比增速高达32%，显示了良好的发展潜力。 刚刚过去的6月，国内另一家以语音见长的医疗AI头部企业云知声也成功上市。从2020年开始，云知声先后四次尝试登陆二级市场，终于在第四次成功上市。其发行价高达205港元，截至7月2日股价已来到286港元，大涨39.5%之多。 医疗板块是云知声的第二大业务板块。根据其招股书，2022年-2024年间，其医疗业务分别取得1.13亿元、1.48亿元和1.99亿元营收，在其总营收中的占比分别为18.9%、20.4%和21.2%，无论营收规模还是在总营收中的占比都在稳步上升。目前，云知声以2.1%的市场份额位列中国医疗服务及治疗AI市场第四。 当所有这些景象都在短时间内出现在一个赛道上时，接下来将要发生什么不言而喻。
Abridge Frequently Asked Questions (FAQ)
When was Abridge founded?
Abridge was founded in 2018.
Where is Abridge's headquarters?
Abridge's headquarters is located at 500 Grant Street, Pittsburgh.
What is Abridge's latest funding round?
Abridge's latest funding round is Series E.
How much did Abridge raise?
Abridge raised a total of $757.5M.
Who are the investors of Abridge?
Investors of Abridge include Khosla Ventures, Andreessen Horowitz, Bessemer Venture Partners, Spark Capital, CVS Health Ventures and 32 more.
Who are Abridge's competitors?
Competitors of Abridge include Nabla, Hippocratic AI, Sayvant, Freed, Suki and 7 more.
What products does Abridge offer?
Abridge's products include Abridge for Clinicians.
Who are Abridge's customers?
Customers of Abridge include UPMC.
Loading...
Compare Abridge to Competitors
DeepScribe automates medical documentation through its platform in the healthcare sector. It provides a medical scribe that captures patient conversations and generates clinical notes, as well as coding support and note personalization for clinicians. It serves the healthcare industry, focusing on specialty care and value-based care. It was founded in 2017 and is based in San Francisco, California.
Corti develops artificial intelligence models for the healthcare sector. Its offerings include AI models that understand medical terminology and patient interactions, designed to integrate into healthcare applications via an application programming interface. The company was founded in 2016 and is based in Copenhagen K, Denmark.
Nabla provides ambient AI technology focused on healthcare documentation and workflow efficiency. The company offers an AI assistant that generates clinical notes in real-time, integrated into electronic health records (EHRs), with the goal of addressing clinician workload and patient care. Nabla's solutions support various medical specialties and can be customized for different clinical needs. It was founded in 2018 and is based in Paris, France.
Hippocratic AI develops large language models for the healthcare sector, focusing on safety in generative artificial intelligence (AI). The company provides AI agents aimed at supporting healthcare accessibility and addressing health outcomes, integrating healthcare expertise. These AI solutions are applicable to different segments in the healthcare industry, including payors, pharmaceuticals, dental, and providers. It was founded in 2023 and is based in Palo Alto, California.
Abstractive Health focuses on artificial intelligence solutions for the healthcare sector, particularly in the area of clinical note management. The company provides a physician AI assistant that summarizes medical records, allowing for the reading and writing of clinical notes. Abstractive Health's technology integrates with existing healthcare systems, facilitating chart retrieval and AI-generated clinical summaries. It was founded in 2022 and is based in New York, New York.
Iodine Software operates as a healthcare artificial intelligence (AI) company that works on mid-cycle revenue operations within the healthcare sector. The company offers a Clinical Intelligence Engine that analyzes clinical data to provide insights and predict outcomes while automating processes, which may help in reducing administrative complexity in the revenue cycle. Iodine Software serves healthcare organizations that aim to enhance financial performance and patient care delivery. It was founded in 2010 and is based in Austin, Texas.
Loading...